| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,778 |
3,035 |
$160K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,144 |
1,832 |
$105K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,338 |
1,174 |
$68K |
| 80053 |
Comprehensive metabolic panel |
1,994 |
1,461 |
$59K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
317 |
268 |
$56K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,584 |
1,978 |
$56K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,420 |
1,176 |
$48K |
| A9270 |
Non-covered item or service |
2,888 |
1,752 |
$32K |
| J2704 |
Injection, propofol, 10 mg |
2,853 |
1,132 |
$27K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,400 |
1,336 |
$26K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
659 |
412 |
$16K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,889 |
926 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
349 |
277 |
$14K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
210 |
177 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,002 |
1,413 |
$11K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
606 |
417 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
985 |
679 |
$10K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,128 |
959 |
$10K |
| 82948 |
|
1,598 |
606 |
$9K |
| 70450 |
Computed tomography, head or brain; without contrast material |
350 |
290 |
$9K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
799 |
552 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,424 |
1,104 |
$7K |
| 82947 |
|
574 |
364 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,571 |
1,821 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
602 |
466 |
$7K |
| G0378 |
Hospital observation service, per hour |
552 |
286 |
$6K |
| J1644 |
Injection, heparin sodium, per 1000 units |
216 |
105 |
$5K |
| 85027 |
|
3,209 |
2,326 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
868 |
481 |
$5K |
| 83735 |
|
846 |
580 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
580 |
332 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,163 |
970 |
$3K |
| 82248 |
|
1,869 |
1,395 |
$3K |
| 81001 |
|
2,012 |
1,677 |
$3K |
| 87631 |
|
35 |
30 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
413 |
346 |
$2K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
702 |
465 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
523 |
336 |
$2K |
| 94762 |
|
800 |
613 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,065 |
1,618 |
$2K |
| 85610 |
|
949 |
697 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
312 |
251 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
995 |
774 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
457 |
384 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
214 |
141 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,937 |
1,476 |
$2K |
| J3490 |
Unclassified drugs |
433 |
270 |
$2K |
| 76942 |
|
106 |
90 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
46 |
37 |
$1K |
| 84132 |
|
356 |
297 |
$912.05 |
| 71046 |
Radiologic examination, chest; 2 views |
650 |
532 |
$785.15 |
| J7050 |
Infusion, normal saline solution, 250 cc |
231 |
146 |
$635.98 |
| 87040 |
|
98 |
40 |
$616.08 |
| 83605 |
|
878 |
684 |
$604.99 |
| 81025 |
|
357 |
317 |
$539.32 |
| 82374 |
|
345 |
288 |
$386.32 |
| 84520 |
|
344 |
287 |
$381.79 |
| 84295 |
|
347 |
289 |
$381.79 |
| 82565 |
|
345 |
287 |
$381.79 |
| 82435 |
|
345 |
288 |
$381.79 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
96 |
79 |
$376.38 |
| 85730 |
|
15 |
13 |
$328.60 |
| 83690 |
|
941 |
747 |
$324.86 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15 |
12 |
$324.55 |
| 87103 |
|
53 |
40 |
$308.04 |
| 83880 |
|
161 |
131 |
$300.53 |
| 76937 |
|
56 |
44 |
$242.30 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
14 |
12 |
$202.26 |
| 80076 |
|
94 |
80 |
$197.40 |
| 84484 |
|
764 |
574 |
$133.44 |
| 86901 |
|
35 |
24 |
$68.34 |
| 88342 |
|
14 |
13 |
$38.40 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
68 |
53 |
$38.10 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
51 |
36 |
$37.97 |
| 0753T |
|
13 |
13 |
$19.77 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
134 |
102 |
$0.00 |
| 86900 |
|
20 |
12 |
$0.00 |
| 88313 |
|
13 |
12 |
$0.00 |
| 84703 |
|
148 |
134 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
266 |
180 |
$0.00 |
| 87077 |
|
16 |
15 |
$0.00 |
| 87070 |
|
28 |
25 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14 |
13 |
$0.00 |
| 86850 |
|
19 |
12 |
$0.00 |
| C1769 |
Guide wire |
13 |
13 |
$0.00 |